In PCa, CDK1 phosphorylated the androgen receptor (AR) and promoted PCa cell proliferation, while CDK1 inhibitors reduced AR phosphorylation and protein expression in PCa cells [39, 40]. The gene discussed is CDK1; the disease is posterior cortical atrophy.